Evaluating ALK Inhibitors in Treatment Sequencing and Testing

Opinion
Video

Dr. Garon discusses the circumstances that might lead him to switch a patient with ALK+ NSCLC from another ALK inhibitor to lorlatinib.

Recent Videos
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
1 expert in this video
1 expert in this video
1 expert in this video
Related Content